SEMMELWEIS UNIVERSITY, SECOND DEPARTMENT OF PAEDIATRICS
Pediatrics – oncology and hematology (chemotherapy toxicity and pharmacokinetics).
Achieve the best therapeutic response with the lowest possible toxicity when using chemotherapeutic agents (e.g., pharmacokinetic modifications).
Prevent severe toxicity of chemotherapeutics in pediatric malignancies.
Comparison of toxicity levels between bolus injection and continuous vincristine infusion in patients with malignancies: a systematic review and meta-analysis.
Comparison of pharmacokinetic parameters and toxicity levels between bolus injection and continuous vincristine infusion in children with hematologic malignancies: protocol and pilot of a prospective randomized trial.
Late effects of anti-cancer therapy in children with hematologic malignancies – focus on VIPN: cross-sectional study and retrospective data analysis.